logo

For the Inventor, By the Inventor

Dublin, Ireland

Prothena Biosciences Limited


USPTO Granted Patents = 60



Trademarks = 9

Forward Citations = 266

Loading Chart...
Loading Chart...

51 inventors (with patents filed for the assignee):

goldMedal Tarlochan S Nijjar (32 out of 49 patents)

silverMedal Robin McDaid Barbour (25 out of 50 patents)

bronzeMedal Yue Liu (18 out of 32 patents)

4.  Philip James Dolan, Iii (14 out of 14 patents)

5.  Jose William Saldanha (10 out of 48 patents)

6.  Avijit Chakrabartty (7 out of 18 patents)

7.  Theodore A Yednock (7 out of 25 patents)

8.  Jeffrey N Higaki (7 out of 12 patents)

9.  Kenneth Flanagan (7 out of 9 patents)

10.  Svetlana Alexander (6 out of 12 patents)

11.  Mark E Renz (6 out of 6 patents)

12.  Wagner Marcelo Zago (6 out of 17 patents)

13.  Kate Dora Games Thiel (5 out of 5 patents)

14.  Peter Andrew Seubert (4 out of 14 patents)

15.  Jeanne E Baker (4 out of 14 patents)


Core Competencies:
AL Amyloidosis
Tau Immunotherapy
Parkinson's Disease
Sortilin Antibodies
Alpha-Synuclein Antibodies
Transthyretin Antibodies
Laminin4 Antibodies
IAPP Antibodies
Immunotherapy Monitoring
Infrared Assay
Humanized Antibodies
Antibody Formulations

60 patents:

1. 12528858 - Humanized Antibodies That Recognize Alpha-Synuclein (2026-01-20),
2. 12479910 - ANTIBODIES RECOGNIZING TAU (2025-11-25),
3. 12240894 - Methods of treating AL amyloidosis (2025-03-04),
4. 12195525 - Tau immunotherapy (2025-01-14),
5. 12084491 - Treatment of Parkinson's disease (2024-09-10),
6. 12049498 - Humanized antibodies recognizing sortilin (2024-07-30),
7. 12049497 - Antibodies recognizing sortilin (2024-07-30),
8. 11958896 - Antibodies recognizing tau (2024-04-16),
9. 11926659 - Antibodies recognizing tau (2024-03-12),
10. 11692024 - Methods of treating AL amyloidosis (2023-07-04),
11. 11643457 - Tau immunotherapy (2023-05-09),
12. 11584791 - Antibodies recognizing tau (2023-02-21),
13. 11492393 - Tau immunotherapy (2022-11-08),
14. 11345749 - Humanized antibodies that recognize alpha-synuclein (2022-05-31),
15. 11237176 - Infrared assay detecting secondary structure profiles of alpha-synuclein (2022-02-01),
Prothena Biosciences Limited is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for people suffering from neurodegenerative and rare diseases. The company's pipeline includes several drug candidates targeting a range of diseases, including AL amyloidosis, Parkinson's disease, and ATTR amyloidosis. With a commitment to scientific excellence and innovation, Prothena aims to transform the lives of patients through its cutting-edge research and development efforts.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

...
60 Patents

#33 in Dublin

#56 in Ireland

#11,810 in the World

...
Dublin, Ireland

Prothena Biosciences Limited

Forward Citations = 266

51 inventors:

goldMedal Tarlochan S Nijjar (32 out of 49 patents)

silverMedal Robin McDaid Barbour (25 out of 50 patents)

bronzeMedal Yue Liu (18 out of 32 patents)

4.  Philip James Dolan, Iii (14 out of 14 patents)

5.  Jose William Saldanha (10 out of 48 patents)

Please report any incorrect information to support@idiyas.com
Loading…